Publications
77 publications
Funding
4 grantsView NIH portfolio on RePORTER ↗
Active
2 grants- PIR21CA313410-01Evaluation of genetic and epigenetic determinants of response in patients with accelerated and blast phase Myeloproliferative Neoplasm (MPNs)NCI · 2026–2028 · via NIH RePORTER
Completed grants (2)
- PIR21CA267632-02Investigation of the impact of pegylated Interferon on clonal trajectory and inflammatory cytokine production in MPN patientsNCI · 2021–2024 · via NIH RePORTER
- PIK08CA188529-05Genomic profiling and development of murine models of transformation of MPNsNCI · 2014–2020 · via NIH RePORTER